Table I.1

Table I.1: The Number of State Pharmacy Regulatory Bodies Reporting That Their Office Has Primary Responsibility for the Oversight of Drug Compounding for Human Use
Type of drug compounder	Number of states (%)
	Yes	No	No response
Drug compounding by pharmacies and pharmacists	50 (100)	0 (0)	0 (0)
Drug compounding by Food and Drug Administration registered outsourcing facilities	35 (70)	13 (26)	2 (4)
Drug compounding by physicians	7 (14)	41 (82)	2 (4)
Drug compounding by other nonpharmacist health care practitioners (e.g., nurse practitioners, physician assistants)	8 (16)	41 (82)	1 (2)

^{Source: GAO survey of state pharmacy regulatory bodies, survey question 2. | GAO-17-363SP}

Note: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey.